249 related articles for article (PubMed ID: 10521545)
1. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone.
Boylan MT; Crockard AD; McDonnell GV; Armstrong MA; Hawkins SA
J Neurol Sci; 1999 Aug; 167(2):79-89. PubMed ID: 10521545
[TBL] [Abstract][Full Text] [Related]
2. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.
Filion LG; Matusevicius D; Graziani-Bowering GM; Kumar A; Freedman MS
Clin Immunol; 2003 Feb; 106(2):127-38. PubMed ID: 12672403
[TBL] [Abstract][Full Text] [Related]
3. The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta.
Shapiro S; Galboiz Y; Lahat N; Kinarty A; Miller A
J Neuroimmunol; 2003 Nov; 144(1-2):116-24. PubMed ID: 14597105
[TBL] [Abstract][Full Text] [Related]
4. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
Liu MF; Li JS; Weng TH; Lei HY
Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes.
Fischer HJ; Finck TLK; Pellkofer HL; Reichardt HM; Lühder F
Front Immunol; 2019; 10():1200. PubMed ID: 31191554
[TBL] [Abstract][Full Text] [Related]
6. Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).
Balabanov R; Lisak D; Beaumont T; Lisak RP; Dore-Duffy P
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1196-203. PubMed ID: 11687463
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis.
Mena E; Rohowsky-Kochan C
Acta Neurol Scand; 1999 Aug; 100(2):92-6. PubMed ID: 10442449
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
11. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.
Girndt M; Sester M; Sester U; Kaul H; Köhler H
Kidney Int; 2001 Apr; 59(4):1382-9. PubMed ID: 11260399
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients.
Folzenlogen D; Hofer MF; Leung DY; Freed JH; Newell MK
Clin Immunol Immunopathol; 1997 Jun; 83(3):199-204. PubMed ID: 9175908
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
14. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.
Köchli C; Wendland T; Frutig K; Grunow R; Merlin S; Pichler WJ
Immunol Lett; 1999 Feb; 65(3):197-201. PubMed ID: 10065743
[TBL] [Abstract][Full Text] [Related]
15. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
[TBL] [Abstract][Full Text] [Related]
16. Monocytes in multiple sclerosis: phenotype and cytokine profile.
Kouwenhoven M; Teleshova N; Ozenci V; Press R; Link H
J Neuroimmunol; 2001 Jan; 112(1-2):197-205. PubMed ID: 11108949
[TBL] [Abstract][Full Text] [Related]
17. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Jensen MA; Yanowitch RN; Reder AT; White DM; Arnason BG
Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
[TBL] [Abstract][Full Text] [Related]
19. Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer.
Luczynski W; Stasiak-Barmuta A; Krawczuk-Rybak M
Cancer Immunol Immunother; 2004 Nov; 53(11):1049-50. PubMed ID: 15449044
[No Abstract] [Full Text] [Related]
20. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
Wiesemann E; Deb M; Trebst C; Hemmer B; Stangel M; Windhagen A
Mult Scler; 2008 Mar; 14(2):166-76. PubMed ID: 17942524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
